DOCTEUR ANNE-MARIE SEREXHE, ANESTHESISTE
0542.900.783 · rovalta.com · 28/09/2026
DOCTEUR ANNE-MARIE SEREXHE, ANESTHESISTE
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODOCTEUR ANNE-MARIE SEREXHE, ANESTHESISTE is a Private limited company incorporated in 2013. Its registered office is in Liège.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0542.900.783
- Incorporation
- 11/12/2013
- Legal form
- Private limited company
- Registered office
- Rue de Fétinne 20
4020 Liège · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 46,6 k € | +27.3% | 36,6 k € | -47.0% | 69,1 k € | +40.3% | 49,3 k € | +209% | 15,9 k € |
| EBITDA | -871,1 k € | -2606% | 34,8 k € | -47.8% | 66,6 k € | +46.1% | 45,6 k € | +255% | 12,8 k € |
| Operating result | -882,9 k € | -5320% | 16,9 k € | -67.6% | 52,2 k € | +132% | 22,5 k € | +318% | -10,3 k € |
| Net result | -892,6 k € | -7976% | 11,3 k € | -70.7% | 38,6 k € | +142% | 16 k € | +205% | -15,3 k € |
| Balance sheet | |||||||||
| Equity | 290,1 k € | -75.5% | 1,2 M € | +1.0% | 1,2 M € | +3.4% | 1,1 M € | +1.4% | 1,1 M € |
| Total assets | 314,2 k € | -74.1% | 1,2 M € | +0.8% | 1,2 M € | +3.1% | 1,2 M € | +0.2% | 1,2 M € |
| Cash | 826,3 € | -89.1% | 7,6 k € | +28.0% | 5,9 k € | +126% | 2,6 k € | +336% | 602,9 € |
| Debts | 24,1 k € | -16.9% | 29 k € | -6.8% | 31,1 k € | -6.2% | 33,2 k € | -28.5% | 46,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ANNE-MARIE SEREXHE | Directorsince 11/12/2013Managerended |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/08/2025 | 26/08/2024 | 07/11/2023 | 31/08/2022 | 31/08/2021 | 08/10/2020 |
| General meeting | 10/06/2025 | 10/06/2024 | 12/06/2023 | 13/06/2022 | 14/06/2021 | 08/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 10/06/2025 | 06/08/2025 | French | |
| Micro model | 31/12/2023 | 10/06/2024 | 26/08/2024 | French | |
| Micro model | 31/12/2022 | 12/06/2023 | 07/11/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/06/2022 | 31/08/2022 | French | |
| Micro model | 31/12/2020 | 14/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 08/09/2020 | 08/10/2020 | French | |
| Micro model | 31/12/2018 | 10/10/2019 | 23/10/2019 | French | |
| Micro model | 31/12/2017 | 13/02/2019 | 21/02/2019 | French | |
| Micro model | 31/12/2016 | 10/10/2017 | 22/02/2019 | French | |
| Abridged model | 31/12/2015 | 26/09/2016 | 26/09/2016 | French | |
| Abridged model | 31/12/2014 | 28/09/2015 | 28/09/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ANNE-MARIE SEREXHE | Directorsince 11/12/2013Managerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue de Fétinne 20, 4020 Liège-4020Current | accounts 2021 → 2024 | Accounts 2024 · 2025-00377628 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DOCTEUR ANNE-MARIE SEREXHE, ANESTHESISTECurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00377628 |
Events
- 2024Annual accounts 2024-892,6 k €↓
- 2023Annual accounts 202311,3 k €↓
- 2022Annual accounts 202238,6 k €↑
- 2021Annual accounts 202116 k €↑
- 2020Annual accounts 2020-15,3 k €↓
- 2019Annual accounts 2019-5,5 k €↓
- 2018Annual accounts 20184,8 k €↓
- 2017Annual accounts 201728 k €↓
- 2016Annual accounts 2016550,5 k €↑
- 2015Annual accounts 2015307,6 k €↑
- 2014Annual accounts 2014228 k €
- 11/12/2013IncorporationPrivate limited company